A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT)

Clinical trial NCT05426369 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05426369
Sponsor: Sichuan Clover Biopharmaceuticals, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-induced Thrombocytopenia (CIT)

Start date: 2022-06-14
Primary completion: 2025-07-02
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.